nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model
|
PENALOZA, A. |
|
2006 |
4 |
1 |
p. 278-281 |
artikel |
2 |
Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets
|
LEONCINI, G. |
|
2006 |
4 |
1 |
p. 209-216 |
artikel |
3 |
Adding the vessel wall to Virchow's triad
|
MANN, K. G. |
|
2006 |
4 |
1 |
p. 58-59 |
artikel |
4 |
An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees
|
KUNICKI, T. J. |
|
2006 |
4 |
1 |
p. 137-147 |
artikel |
5 |
Announcements
|
|
|
2006 |
4 |
1 |
p. 294 |
artikel |
6 |
A novel compound heterozygous mutation in the F13A gene causing hereditary factor XIII deficiency in a Chinese family
|
WU, S. |
|
2006 |
4 |
1 |
p. 267-269 |
artikel |
7 |
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
|
NAESS, I. A. |
|
2006 |
4 |
1 |
p. 44-49 |
artikel |
8 |
A rapid enzyme-linked assay for ADAMTS-13
|
WU, J.-J |
|
2006 |
4 |
1 |
p. 129-136 |
artikel |
9 |
CHO cells expressing the high affinity αIIbβ3T562N integrin demonstrate enhanced adhesion under shear
|
LEGENDRE, P. |
|
2006 |
4 |
1 |
p. 236-246 |
artikel |
10 |
Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction
|
HOSHIBA, Y. |
|
2006 |
4 |
1 |
p. 114-120 |
artikel |
11 |
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis
|
DI NISIO, M. |
|
2006 |
4 |
1 |
p. 52-57 |
artikel |
12 |
C-reactive protein contributes to the hypercoagulable state in coronary artery disease
|
SONG, C. J. |
|
2006 |
4 |
1 |
p. 98-106 |
artikel |
13 |
Deficiency of thrombospondin-1 in mice does not affect adipose tissue development
|
VOROS, G. |
|
2006 |
4 |
1 |
p. 277-278 |
artikel |
14 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
|
EATON, D. |
|
2006 |
4 |
1 |
p. 260-261 |
artikel |
15 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
|
HENDRIKS, D. F. |
|
2006 |
4 |
1 |
p. 261-262 |
artikel |
16 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
|
BERTINA, R. M. |
|
2006 |
4 |
1 |
p. 256-257 |
artikel |
17 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
|
CAMPBELL, W. |
|
2006 |
4 |
1 |
p. 259 |
artikel |
18 |
Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
|
BOUMA, B. N. |
|
2006 |
4 |
1 |
p. 257-258 |
artikel |
19 |
Editorial
|
MANNUCCI, P. M. |
|
2006 |
4 |
1 |
p. 1-2 |
artikel |
20 |
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis
|
ÅGREN, A. |
|
2006 |
4 |
1 |
p. 201-208 |
artikel |
21 |
Factor XIII (FXIII) and angiogenesis
|
DARDIK, R. |
|
2006 |
4 |
1 |
p. 19-25 |
artikel |
22 |
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice
|
HAYASHI, M. |
|
2006 |
4 |
1 |
p. 177-185 |
artikel |
23 |
Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregation
|
SALEM, R. O. |
|
2006 |
4 |
1 |
p. 275-276 |
artikel |
24 |
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
|
AL DIERI, R. |
|
2006 |
4 |
1 |
p. 83-89 |
artikel |
25 |
Forthcoming articles in the February issue
|
|
|
2006 |
4 |
1 |
p. xv-xvi |
artikel |
26 |
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. A rebuttal
|
RIONDINO, S. |
|
2006 |
4 |
1 |
p. 291-292 |
artikel |
27 |
Further evidence that fibrillar collagen is unable to promote platelet shape change and aggregation in the absence of secondary agonists. Reply to a rebuttal
|
OHLMANN, P. |
|
2006 |
4 |
1 |
p. 292-293 |
artikel |
28 |
Identification and characterization of murine alternatively spliced tissue factor
|
BOGDANOV, V. Y. |
|
2006 |
4 |
1 |
p. 158-167 |
artikel |
29 |
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism
|
SIMON, T. |
|
2006 |
4 |
1 |
p. 71-76 |
artikel |
30 |
Inherited defects of coagulation factor V: the hemorrhagic side
|
ASSELTA, R. |
|
2006 |
4 |
1 |
p. 26-34 |
artikel |
31 |
Inherited defects of coagulation Factor V: the thrombotic side
|
VOS, H. L. |
|
2006 |
4 |
1 |
p. 35-40 |
artikel |
32 |
Inhibition of 5-hydroxytryptamine2A receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery
|
NISHIHIRA, K. |
|
2006 |
4 |
1 |
p. 247-255 |
artikel |
33 |
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No
|
AGNELLI, G. |
|
2006 |
4 |
1 |
p. 14-15 |
artikel |
34 |
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question
|
LEVINE, M. |
|
2006 |
4 |
1 |
p. 16-18 |
artikel |
35 |
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups
|
HUISMAN, M. V. |
|
2006 |
4 |
1 |
p. 10-13 |
artikel |
36 |
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function
|
BARONI, M. |
|
2006 |
4 |
1 |
p. 186-191 |
artikel |
37 |
More on: discovery of α2-plasmin inhibitor and its congenital deficiency
|
GALLIMORE, M. J. |
|
2006 |
4 |
1 |
p. 284-285 |
artikel |
38 |
More on: pathogenic antibodies to coagulation factors. Part II: fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, protein C and von Willebrand factor
|
JONES, D. W. |
|
2006 |
4 |
1 |
p. 282-284 |
artikel |
39 |
More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation
|
MARIETTA, M. |
|
2006 |
4 |
1 |
p. 288 |
artikel |
40 |
More on: the role of thrombin in gliomas
|
ARBIT, E. |
|
2006 |
4 |
1 |
p. 286 |
artikel |
41 |
Mutations C1157F and C1234W of von Willebrand factor cause intracellular retention with defective multimerization and secretion
|
HOMMAIS, A. |
|
2006 |
4 |
1 |
p. 148-157 |
artikel |
42 |
New epidemiological risk factors for venous thromboembolism (VTE) after menopause
|
GRANDONE, E. |
|
2006 |
4 |
1 |
p. 70 |
artikel |
43 |
No significant improvement in diagnostic specificity of an anti-PF4/polyanion immunoassay with use of high heparin confirmatory procedure
|
WARKENTIN, T. E. |
|
2006 |
4 |
1 |
p. 281-282 |
artikel |
44 |
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement
|
ERIKSSON, B. I. |
|
2006 |
4 |
1 |
p. 121-128 |
artikel |
45 |
Plasma D-dimer assays in the diagnosis of venous thromboembolism in cancer patients
|
HUNT, B. J. |
|
2006 |
4 |
1 |
p. 50-51 |
artikel |
46 |
Platelet membrane glycoproteins: historical perspectives
|
NURDEN, A. T. |
|
2006 |
4 |
1 |
p. 3-9 |
artikel |
47 |
Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI
|
LIVNAT, T. |
|
2006 |
4 |
1 |
p. 192-200 |
artikel |
48 |
Prophylaxis of venous thromboembolism in general and gynecologic day surgery in the Netherlands
|
WASOWICZ-KEMPS, D. K. |
|
2006 |
4 |
1 |
p. 269-271 |
artikel |
49 |
Protein S binding to phospholipids: evaluation of eight variants of recombinant human protein S from the PROSIT study
|
RAZZARI, C. |
|
2006 |
4 |
1 |
p. 273-274 |
artikel |
50 |
Reply to more on: the role of thrombin in gliomas
|
HUA, Y. |
|
2006 |
4 |
1 |
p. 287 |
artikel |
51 |
Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis
|
WU, X.-X |
|
2006 |
4 |
1 |
p. 271-273 |
artikel |
52 |
Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults
|
JENNY, N. S. |
|
2006 |
4 |
1 |
p. 107-113 |
artikel |
53 |
Superficial thrombophlebitis of the legs: still a lot to learn. A rebuttal
|
BOUNAMEAUX, H. |
|
2006 |
4 |
1 |
p. 289 |
artikel |
54 |
Superficial thrombophlebitis of the legs: still a lot to learn. Reply to a rebuttal
|
DECOUSUS, H. |
|
2006 |
4 |
1 |
p. 290 |
artikel |
55 |
Synthesis of GPIbβ with novel transmembrane and cytoplasmic sequences in a Bernard–Soulier patient resulting in GPIb-defective signaling in CHO cells
|
STRASSEL, C. |
|
2006 |
4 |
1 |
p. 217-228 |
artikel |
56 |
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin
|
KJELLBERG, M. |
|
2006 |
4 |
1 |
p. 168-176 |
artikel |
57 |
The importance of measuring anticardiolipin antibodies
|
DE GROOT, P. G. |
|
2006 |
4 |
1 |
p. 41-43 |
artikel |
58 |
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-β2-glycoprotein-1 ELISAs
|
LEWIS, D. A. |
|
2006 |
4 |
1 |
p. 265-267 |
artikel |
59 |
The regulation of endothelial VWF secretion by nitric oxide: is it physiological?
|
ZAREI, S. |
|
2006 |
4 |
1 |
p. 263-265 |
artikel |
60 |
The Ser219–>Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype
|
QU, D. |
|
2006 |
4 |
1 |
p. 229-235 |
artikel |
61 |
Thrombin generation in vascular tissue
|
PATHAK, A. |
|
2006 |
4 |
1 |
p. 60-67 |
artikel |
62 |
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
|
KIENAST, J. |
|
2006 |
4 |
1 |
p. 90-97 |
artikel |
63 |
Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response
|
VAN ROOIJEN, M. |
|
2006 |
4 |
1 |
p. 77-82 |
artikel |